Skip to main content
. 2009 Jul 13;3(5):241–251. doi: 10.1111/j.1750-2659.2009.00095.x

Table 1.

 Comparison of TCID50 titers of influenza A and B virus on ELVIRA Flu A‐luc and Flu B‐Rluc cells and MDCK cells

Virus strain Method*
ELVIRA Flu A Luc MDCK
A
 A/Brisbane/59/2007 (H1N1) 1·08E + 07 1·26E + 07
 A/Solomon island/03/2006  (H1N1) 1·58E + 07 1·99E + 07
 A/Wisconsin/56/2005 (H3N2) 1·80E + 07  1·19E + 07
 A/Mal/302/54 (H1N1) 2·59E + 07  8·89E + 06
 A/Whooperswan/Mongolia/  244/05 (H5N1) 1·78E + 08    1·2E + 08
 A/Hong Kong/483/97 (H5N1) 5·01E + 07  2·51E + 06
 A/Hong Kong/486/97 (H5N1) 2·09E + 08  1·17E + 07
 A/Vietnam/1203/04 (H5N1) 2·57E + 07  3·31E + 07
B
 B/Malaysia2506/04 5·00E + 07 2·32 E + 07
 B/GL/1739/54 5·00E + 05 1·25 E + 06
 B/Florida04/2006 5·00E + 06 2·59 E + 06

*Ten‐fold serial dilutions of influenza A or B virus stocks were made in serum free medium. ELVIRA Flu A and MDCK cells were planted in 96‐well plates and then infected with the 10−4 through 10−9 dilutions (10 wells/dilution). After infection, the cells were incubated at 37°C with 5% CO2 for 24 or 48 hours (ELVIRA cells) or 4 days (MDCK cells). ELVIRA Flu A luc and ELVIRA Flu B Rluc wells with a RLU reading of >3 times the background mean were considered positive for influenza infection. MDCK cells were inspected microscopically for cytopathic effects. TCID50 was calculated by the Reed & Muench method.